Therefore, in the present study, a high-throughput transcriptome sequencing approach was adopted to investigate the transcriptome profiles of NB cells in which the expression of ZBTB38 gene was down-regulated, thus revealing the potential biomarkers associated with anti-tumor therapies for NB. Here, ZBTB38 is linked to neuroblastoma.